Continued Impact of Drug Shortages During the COVID-19 Pandemic

Start Course Now

Class A Credits: 0.5

Format: Video

Run time: 14 mins

Course Launch Date: 7/13/20

Course Expires: 7/12/21

Understand the causes and implications of current drug shortages and how they impact clinical practice as elective surgeries resume.       


Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:

The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.

  • To expand on the current state of drug shortages, government actions, formulary considerations, and mitigation strategies.
  • To describe implications to clinical practice and infection control, particularly as elective surgeries resume.

Lorraine Jordan, PhD, CRNA, CAE, FAAN

Chief Advocacy Officer - AANA



Michael Anderson, DNP, CRNA, ARNP

Clinical Coordinator

Mike Anderson is a Clinical Nurse Anesthetist at the University of Iowa Hospitals and Clinics and is a Clinical Assistant Professor and Clinical Coordinator of the Anesthesia Nursing Program in the College of Nursing at the University of Iowa. Dr. Anderson graduated with a Masters Degree from the Cleveland Clinic/Case Western Reserve University Nurse Anesthesia Program in 2009 and obtained his DNP from the University of Iowa in May, 2014. His Doctoral work focused on Infection Control in the Operating room. He has held almost every elected position with the Iowa Association of Nurse Anesthetists including President from 2016-2018 and has served on numerous AANA and NBCRNA committees. Dr. Anderson served as the Emerging Leader Fellow on the NBCRNA board from 2014-2016. He served on the AANA Cultural Assessment Task Force and is currently on the AANA Practice Committee.



Michael Ganio, PharmD, MS, FASHP

Director Pharmacy Practice and Quality at American Society of Hospital Pharmacists

Dr. Ganio joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, sterile and nonsterile drug compounding practices, and hazardous drug safety.

 

Dr. Ganio earned his Pharm.D. from Rutgers University Ernest Mario School of Pharmacy, and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center.

 

Dr. Ganio has over 17 years of hospital and health-system experience. His previous job roles have included clinical pharmacy practice, pharmacy informatics and technology, and operations management of outpatient oncology infusion pharmacies. He has extensive knowledge of pharmacy informatics and automation, medication billing and reimbursement, outpatient infusion and ambulatory care models, and sterile compounding.

 

Dr. Ganio is a Board Certified Pharmacotherapy Specialist and is a Certified Professional in Healthcare Information and Management Systems. He has previously served as President of the Ohio Society of Health-System Pharmacists and as a member of the ASHP Council on Pharmacy Practice.



Michael Schneider, MBA

Principal at Avalere Health


rocket-idle